(441 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 InflammationOpening remarks Santiago Quirce ...
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseasesWelcome and introduction Peter Howarth, G....
-
IL-5 inhibition in CRSwNP and severe asthma: impact beyond the eosinophilWelcome For the sci...
-
Targeting eosinophils in severe asthma: real-world data and clinical remissionChair’s welcome Biologics ...
-
Pediatric Severe Asthma: Why Lung Function Matters
-
Reconsider the art of AITWelcome and introduction Pati...
-
Filling the gaps in asthma careTraining the immune system with microbial products ...
-
Severe type 2 asthma: phenotypes and precision treatment for patientsOpening remarks Stephanie Korn, Enrico Hef...
-
SCIT; pioneering a new eraIntroduction Venom Immunothe...
-
Relegating OCS to last resort: Creating a paradigm shift in asthma managementAstraZeneca: Relegating OCS to last resort: Creating a paradigm shift in asthma management...
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
Type 2 Inflammation: What every clinician should knowHans In‘t Veen, Jasper Kappen This Company Sponsored Symposia...
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascadeIoana Agache, Andrew Menzies-gow, Stephanie Korn, Celeste Porsbjerg
-
Mite – the “diva” in AIT trialsWelcome and introduction Fill...
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?Welcome & Introduction Jonathan Grigg...
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
Systemic Mastocytosis – An Allergist/Immunologist PerspectiveVito Sabato
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?Guy Brusselle, Klaus F. Rabe This Company Sponsored Symposia ha...
-
Patients’ perspective : a must have for the future of Allergen ImmunotherapyIntroduction What can a patie...
-
IgE in asthma and nasal polyposis: your questions answered
-
Peanut allergy and investigational DBV712: an updateIntroduction Antonella Muraro ...
-
From Past to Present: What’s next for CSU?Welcome and Introduction Ses...
-
Pioneering a new age – fighting allergic disease on all fronts!Introduction video Introducti...
-
Advances in eosinophilic diseases
-
Rethinking hereditary angioedema: What role can the first oral plasma kallikrein inhibitor play?Reflection on hereditary angioedema (HAE): Progress and perspectives ...
-
Everything you always wanted to know about SCIT but were afraid to askSCIT: Long-term efficacy Andrzej Bozek ...
-
Meet the experts on AIT in Food AllergyWelcome & Introduction Hans Van Schij...
-
To eat or not to eat: that is the questionNutrition and gut health for prevention of food allergy ...
-
Ameliorating atopy by targeted micronutrient supplementation with beta-lactoglobulinFranziska Roth-Walter
-
Focus on TAKHZYRO and real-world evidence: Why it matters for your patients with hereditary angioedema (HAE)Welcome and introduction Milos Jesenak ...
-
Evolving patient journeys in food allergyWelcome and Introduction Ses...
-
Allergic patient: The Real WorldIntroduction European patient...
-
Exploring the Complexity of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria (CSU): unpredictable, chronic and burdensome ...
-
Chronic spontaneous urticaria: defining the pathway to successful managementWelcome and Introduction Marcus Maurer ...
-
Patients with peanut allergy: the hope for a better life?Introduction Antonella Muraro ...
-
IgE-mediated food allergy: need for a revolutionPanel discussion: Why do we need to be concerned about food allergy? What is the role of I...
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Hereditary angioedema (HAE): no patients left behindWelcome and introduction HAE ...
-
Allergen immunotherapy with allergoid-mannan conjugates: from basic science to clinical researchIntroduction The allergoid-ma...
-
Progression of Type 2 Inflammatory Diseases in Different Organ Systems in Pediatric Patients
-
Advancing the management of CMPA with HMO: Priming the immune systemIntroduction The clinical rel...
-
Allergen composition of preparations translate into clinical outcomes of AITWelcome and introduction Suzanne Lau ...
-
Autoimmunity and immune deficits in IEI – uncovering APDSWelcome and Introduction Diag...
-
Exploring the Role of Type 2 Inflammation in Dermatologic DiseasesAtopic Dermatitis and the Type 2 Inflammatory Disease Spectrum ...
-
Navigating Type 2 Inflammation across the skin, airway, and esophagusNavigating Type 2 Inflammation across the skin, airway, and esophagus ...
-
Efficacy and quality of life in HAE: The lanadelumab experience
-
Treating peanut allergy with oral immunotherapy: new data and practical experienceIntroduction Jonathan O’B Hourihane ...
-
How can we improve the approach to treating chronic urticaria in children?Introduction Montserrat Alvaro Lozano ...
-
Targeting Type 2 mechanisms in patients with atopic dermatitis and comorbid Type 2 Inflammatory disease: A case-based reflectionConnecting Type 2 Inflammation to clinical characteristics of disease
Show more Sponsored Symposia (51)Show Less-
-
EAACI Biologicals Guidelines - Recommendations for severe asthmaAbstract Severe asthma imposes a significant burden on patients, families and healthcare ...
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthmaAbstract Allergen immunotherapy (AIT) has been in use for the treatment of allergic disea...
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthmaAbstract Adolescent and young adult (AYA) patients need additional support, while they ex...
-
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitisAbstract Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes a...
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergyAbstract Hymenoptera venom allergy is a potentially life-threatening allergic reaction fo...
-
EAACI guidelines on allergen immunotherapy: Prevention of allergyAbstract Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT...
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergyAbstract Food allergy can result in considerable morbidity, impairment of quality of life...
-
EAACI Biologicals Guidelines - Treatment with biologicals for severe chronic rhinosinusitis with nasal polypsThe upcoming “Guidelines – treatment with biologicals for severe chronic rhinosinu...
-
EAACI Biologicals Guidelines - dupilumab for children and adults with moderate-to-severe atopic dermatitisAbstract Atopic dermatitis imposes a significant burden on patients, families and healthc...
-
Anaphylaxis: guidelines from the EAACIAbstract Anaphylaxis is a clinical emergency, and all healthcare professionals should be ...
-
EAACI guidelines on environmental science in allergic diseases and asthma - Leveraging artificial intelligence and machine learning to develop a causality model in exposomicsThis narrative review is regarded as part of the upcoming “Guidelines on environment...
-
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)Abstract Background: This guideline from the European Academy of Allergy and Clinical I...
-
World Health Organization global air quality guideline recommendations: Executive summaryAbstract Air pollution is a leading cause of death globally and has resulted in the loss ...
-
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergyAbstract Food allergy can result in considerable morbidity, impact negatively on quality ...
-
The international WAO/ EAACI guideline for the management of hereditary angioedema - The 2021 revision and updateAbstract Hereditary angioedema (HAE) is a rare and disabling disease for which early diag...
-
The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticariaAbstract This update and revision of the international guideline for urticaria was develo...
Show more Guidelines (14)Show Less-
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma For the EU‐funded project PERMEABLE (PERsonalized MEdicine Approach for asthma and aller...
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthmaHigh expression of such endopeptidases may be associated not only with a higher risk of SA...
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma RegistryDespite the clinical burden of severe asthma is substantial, there is evidence of a neutra...
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsIn conclusion, in our large cohort of severe asthmatics, only a small minority experienced...
-
DGAKI statement on asthma and COVID-19AIT and COVID-19 March 18, 2020 Dear colleagues, In the past few days, we have received mo...
-
Risk factors for severe and critically ill COVID-19 patients: A reviewIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
Delayed virus‐specific antibody responses associate with COVID‐19 mortalityCollectively, for the first time, our study provides evidence that delayed antibody respon...
-
Atopic status protects from severe complications of COVID‐19In conclusion, atopic status seems to protect against the most severe, often fatal consequ...
-
African American children are at higher risk for COVID‐19 infection“Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the ...
-
Is there a role for childhood vaccination against COVID-19?Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect vuln...
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2Asthma and respiratory allergies have not been identified as risk factor for severe Covid-...
-
Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild courseThus, with the here presented cases we support the AMS declaration that MMR vaccination, a...
-
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community CohortThis interesting article shows that the ApoE e4e4 allele increases risks of severe COVID-1...
-
Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectivesAbstract Vaccines are essential public health tools with a favorable safety profile and pr...
-
The younger the milder clinical course of COVID-19 - even in infants? Neonates appeared to bear more severe clinical courses. In addition to higher case fatalit...
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma SectionAbstract Background The restrictions imposed by the COVID-19 pandemic impact heavily the m...
-
COVID-19 Pandemic and allergen immunotherapy - an EAACI surveyAs in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in a...
-
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsOur findings might have important implications for the definition of asymptomatic COVID‐...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
Show more Covid-19 (17)Show Less-
-
Bronchiectasis and severe asthma
-
Immunotherapy in severe asthma (AIT)
-
The basics of severe asthma - biomarkers
-
Focus on Patient. Personalised therapy for severe asthma
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Efficacy and safety of masitinib in severe asthma: Eosinophilic subgroup analysis from study AB07015
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
-
Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
-
Severe Asthma and COVID-19
-
Electronic Health in Severe Asthma
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Elderly asthma
-
Updates in [severe] asthma in adults
-
Viral infection and asthma
-
Tezepelumab (anti-TSLP) in asthma
-
Exercise: induced asthma and rhinitis
-
Targeted approaches for asthma
-
Late onset T2 asthma – a case study
-
Benralizumab in severe eosinophilic asthma… Or is it something else?
-
Elevated tryptase – Now what?
-
When hives are not chronic urticaria
-
Telemedicine and Tele-health
-
Danger signs
-
Difficult to control asthma in adults
-
Assessment of adherence to treatment using mHealth
-
Difficult to control asthma in children
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
Hologenome and obesity
-
Big changes in asthma treatment : GINA 2019
-
Adherence: A challenge for Immunotherapy
-
How to improve outcomes
-
Implementation of telehealth in asthma management: trials and tribulations
-
Allergy to Kale
-
New perspectives for anaphylaxis
-
Delabelling adults
-
Novel pharamacological targets
-
Predicting adverse reactions to biologicals
-
Impact of climate change on asthma exacerbations
-
Phenotypes and Endotypes
-
A system biology and machine learning approach to childhood asthma
-
How to select and follow a biological for asthma and CRSwNP
-
Differential diagnosis
-
Asma e alergia em Angola
-
Sleep patterns and development of children with atopic dermatitis
-
AAAAI Practice Parameters
-
Early life wheeze - risk factors for asthma in school age
-
Asma e alergia em pandemia
-
Current and future perspectives
-
Novel approaches of allergen immunotherapy
-
Pediatric Asthma in Real Life (PeARL): addressing controversies in pediatric asthma
-
What’s different about the adolescent brain?
-
Allergen immunotherapy for food allergy
-
Management of adverse reactions to biologics
-
Microbiota in immune-based therapies
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Should we do patch testing in children with eczema?
-
Novel insight into development of allergic diseases
-
Current status on prophylaxis in HAE
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Gut microbiome - based therapeutic approaches
-
Collective advocacy for action on CRDs
-
Measles infection causes immune amnesia
-
Route of exposure determines the immune response to food allergens
-
Living with food allergy
-
Can we prevent the development of food allergy?
-
The brain, nose, immune axis
-
Asthma: phenotypes to endotypes
-
Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
-
Tree nut allergy: path from national to global data
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Recognizing immediate reactions in contact dermatitis
-
Prevention of food allergy: where are we now?
-
Development of a childhood asthma prediction model using machine learning approaches
-
Unusual presentations of contact dermatitis
-
Plans of GARD in terms of surveillance after COVID
-
An update on prevention of allergic diseases
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Novel cell based assays in allergy diagnostics
-
Bronchial allergen challenge in the clinic
-
Exercise-induced urticaria and anaphylaxis
-
Diagnosis of insect venom allergy: back to basics
-
Environment and Immunology StandUp TalksSpeakers ...
-
Can the birch pollen be more aggressive in the polluted environments?
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Lung function testing
-
Neuroimmunology and allergy
-
Vaccines for older adults: benefits and limitations
-
Linking bovine milk components and their possible association with allergic diseases
-
Implementing component resolved diagnostics in allergy diagnosis
-
Mental health needs and access to care among patients with food allergy
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Role Viral reactivations
-
Early biomarkers for severe drug hypersensitivity reactions
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Do adrenaline auto-injectors save lives?
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
The clinical clues and pitfalls in contact dermatitis
-
Bronchial allergen challenge in research
-
Role of antigen-presenting cells in tolerance and allergy
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Biologicals in allergy and asthma: A deep learning approach to optimized patient management
-
Prevention and therapy in primary immunodeficiencies: Vaccination
-
2'FL and LNnT shape the gut microbiome and metabolome in CMPA
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
Therapies for multiple-tree nut allergies
-
Virtual care, social media and mHealth for allergy management
-
Is anaphylaxis really rare in children?
-
Treating allergic patients during the COVID-19 pandemic
-
Eosinophilic fasciitis, an unusual presentation
-
Benralizumab efficacy for severe, eosinophilic asthma with a diagnosis of nasal polyposis: Results from the phase IIIb ANDHI trial
-
Covid-19 in "Allergy" journal
-
Endotype-driven treatment in chronic rhinosinusitis
-
AI models
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Hypersensitivity to antiepileptic drugs
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Desensitization in chemotherapy and biologics
-
GINA Guidelines Update
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
The α2β1 integrin, a collagen-binding receptor, may be involved in pathology of airway remodelling in asthma
-
Seasonal variability of exacerbations in patients with severe, uncontrolled asthma and clinical benefits of tezepelumab: Results from the PATHWAY phase 2b study
-
The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study
-
Asthma management during the COVID-19 pandemics
-
Preparing a grant: Dos and Don'ts
-
What are the best end-points in AIT asthma trials - the clinician point of view?
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Mechanisms of airway remodeling unique to eosinophilic asthma: Insights from differential gene co-expression analysis
-
Environmental epigenomics of allergy
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
The effect of tezepelumab in patients with allergic and non-allergic asthma: results from the NAVIGATOR phase 3 study
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Precision Medicine and AIT
-
Impact of omalizumab on severe food allergy in 54 italian patients with concomitant asthma: 6-year-long experience
-
E-cigarettes: mechanistic link to lung injury
-
Risk assessment and active management of food allergy
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Wild-fires, pollution, climate change and other threats
-
The engineering-medicine interface
-
How to evaluate lung function? Hands-on plus lecture
-
Is IgA a piece of the EoE puzzle?
-
Big Data Analysis: MetabolomicsView Presentation
-
Immunological basis of food aversion
-
New insights in urticaria mechanisms
-
Chronic rhinosinusitis with nasal polyps
-
Update of the WAO anaphylaxis guidance
-
It looks like urticaria – but is it?
-
When to evaluate children with atopic dermatitis for Type IV allergy
-
Potential role of mir-185-5P as feedback mechanism for controlling airway remodeling and smooth muscle contraction
-
Covid 19 and air pollution: is there a relationship?
-
Urban green spaces - The exposure and allergenicity index
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
AIT in the pediatric population
-
FAAM-EUROBAT Opening ceremony
-
Primary care in CRDs during COVID
-
Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy
-
Over-the-counter allergy prevention weaning products
-
Food allergy: new allergens on the block
-
House dust mite allergen-specific immunotherapy using an adjuvant- and allergoid-based approach in a murine model of allergic asthma
-
Hypereosinophilic syndromes and autoimmunity
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Phenotypes and endotypes of occupational allergy
-
The impact of the exposome on allergies and asthma – a global view on urbanisation, climate change and pollution
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Precision medicine and biomarkers of atopic dermatitis
-
Precision Medicine and integrated care pathways in 2020 and beyond
-
Big data and cluster analysis: a real life perspective
-
Psychological support to peanut allergic children and their families
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
Inflammatory biomarkers
-
Worldwide survey shows that atopic dermatitis is associated with a high disease burden in adolescents
-
Does human milk and its composition matter for development and prevention of allergies?
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Healthcare use and asthma control among overweight/obese urban children sensitized and exposed to classroom allergens
-
Launch of the Biological guidelines
-
What do we learn from subgroup analyses in phase-III trials?
-
Autoimmunity in atopic diseases
-
Understanding parent preferences for paediatric allergy services
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
What is the immunological basis for new biologicals?
-
Insight from translational research on oral tolerance induction through breast milk
-
Skin mycobiome sequencing reveals a high fungal diversity in patients with severe atopic dermatitis
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
How do allergens sensitize?
-
Impaired olfaction: diagnostics and its role in diseases
-
Skin care from birth for allergy prevention: results today
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Cellular tests for the diagnosing and monitoring of allergy
-
Alternative free-from foods to reach a balanced diet
-
Immune responses in desentitization and tolerance
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
Genetic polymorphisms of CD14 and TLR-4 and utility of probiotic therapy in adults with atopic dermatitis
-
Scraping nasal cytology in the diagnostics of the respiratory tract diseases
-
The ‘allergy tool kit’ for the transition clinic
-
Air pollution and allergy: call for action!
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Novel therapeutic approaches targeting endotypes of severe airway disease
-
Developing an adolescent and young adult allergy service
-
Can group consultations work in allergy? Learning from rheumatology
-
How to keep a child with anaphylaxis safe in school
-
Social media and Allergies: how can we support our patients?
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Tackling anaphylaxis
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Fractional exhaled nitric oxide levels and eosinophil counts after cessation of tezepelumab: Results from the PATHWAY phase 2b study
-
Assessing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) severity by JESREC algorithm
-
Higher levels of epitope-specific IgE are associated with failure to respond to OIT in baked-egg reactive patients
-
Durable reduction in hereditary angioedema (HAE) attack rates with berotralstat over 24 months: results from the phase 3 apeX-2 study
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Oral food challenges thresholds for clinical reactions
-
Update on drug allergy
-
MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study
-
FeNO, forced oscillation, or spirometry? Lung function testing in wheezy pre-schoolers and the prediction of asthma, a systematic review
-
Occupational respiratory allergy in food processing industries
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Efficacy of dupilumab in children with uncontrolled, moderate-to-severe type 2 asthma, with/without evidence of allergic asthma: the VOYAGE phase 3 study
-
Evidence of immunotherapy on allergy prevention?
-
Food industry perspective
-
Food allergy - the beginners guide
-
Moisturisers for the primary prevention of food allergy
-
Using the “atopic dermatitis yardstick” in clinical practice
-
Flexible and rigid dendrimer-based nanostructures for cell effector studies in the context of amoxicillin allergy
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
How can we improve the quality of life of patients with severe food allergy?
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
An update on food allergy
-
Probiotics and prebiotics: an on-going journey
-
Impacting quality of life with PALFORZIA
-
ISMA-RHINA Opening Ceremonyhttps://services.y-congress.com/congress/medias/2022/EAACI-ISMA-RHINA-2022/1/video/y_1080p...
-
ISMA-RHINA Closing Ceremony
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Biotin interference can cause false-negative IgE test results in patients with anaphylaxis
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
How to use social media in your professional practice: the clinician perspective
-
Molecular allergology in daily clinical practice
-
Molecular and structural considerations for aerosolization of food allergens
-
Dupilumab reduces severe exacerbations in patients with uncontrolled, moderate-to-severe allergic (atopic) asthma regardless of presence of perennial aeroallergen-specific IgE: LIBERTY ASTHMA QUEST
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Immune response to Corona virus infection
-
Reduction in rescue medication use in patients treated with the 300IR house dust mite slit table
-
The role of infection in chronic spontaneous urticaria
-
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
-
EAACI Guideline on NAR: does it need to be updated?
-
Immune regulation in specific B cells in food allergy, tolerance and outgrowing children
-
New and clinically relevant contact allergens
-
Placebo effects is an integrated part of the treatment benefits of AIT (Pro & Con Session: Pro)
-
Dysregulated regulation of skin structure and barrier function by insufficient IL-37 in allergic inflammation of atopic dermatitis
-
Long-term dupilumab treatment for 100 weeks reduces serum TARC and total IgE in patients with moderate-to-severe atopic dermatitis
-
EAACI Guidelines on environmental health
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
Large spectrum response to Dupilumab in a patient with atopic multimorbidity
-
Anaphylaxis in ICD-11
-
Are drug provocation tests required before decision to desensitize?
-
Implementing biomarkers in immunophenotyping of atopic dermatitis
-
Mechanisms of non IgE mediated food allergy
-
A patient with an acute reaction: recognize, document and treat
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Structural biology of food allergens and cross reactivity
-
Integrated systems biology strategies for diagnostics and immune monitoring in allergy
-
Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study
-
How to classify cutaneous manifestations of drug hypersensitivity
-
Three-year follow-up of the 2016 Melbourne Epidemic Thunderstorm Asthma patients: Insight into symptoms, healthcare seeking, and medication compliance
-
Long-term safety and tolerability of Berotralstat (BCX7353) for Hereditary Angioedema (HAE) prophylaxis: APeX-S study results
-
Using BAT for differentiation between sensitization and allergy to alpha-gal
-
Non-T2 directed biologicals
-
Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
-
Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Con)
-
Cow's milk allergy guidelines promote over-diagnosis of milk allergy (Pro & Con Session: Pro)
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
The dilemma of food allergy additives
-
Changes in disease activity and treatment patterns in patients with chronic urticaria during pregnancy: Results of the PREG-CU study, a UCARE project
-
Differences in epitome response in peanut-allergic subjects treated with different immunotherapy preparations
-
B cell tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy
-
Challenges on the implementation of early introduction of allergenic foods
-
Interferon therapy in airway disease: prophylaxis is the new approach in exacerbation prevention?
-
Immune modulation in local allergic rhinitis
-
Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines
-
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
-
Effects of tezepelumab on asthma exacerbations, type 2 biomarkers, lung function and asthma control in patients with severe, uncontrolled asthma with and without nasal polyps: PATHWAY phase IIb study
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Precision medicine in immunodeficiency
-
Nasal allergen challenge
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Peripheral blood regulatory T cells and their influencing factors on atopic dermatitis development in West Highland white terriers
-
Basophil sensitivity during immunotherapy in grass pollen-allergic patients
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Airborne enzymes – New and re-emerging occupational hazards
-
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
-
Food diversity during the first year and risk of atopic eczema and food allergy up to 12 years of age
-
Impact of climate change on the immune system
-
Recognition of synthetic antigenic determinants of clavulanic acid in patients with immediate allergic reactions to beta-lactams using lymphocyte transformation test
-
Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
We are what we eat - importance of food to health, moving past simple calories
-
Lesson learned from the pathogenesis of SARS-COV2
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
The need to target B cell responses during peptide immunotherapy: revisiting the concept of tolerance
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs
-
Shaping lifelong immune health: A network-based strategy to predict and prioritize markers related to immune interventions in early life
-
Protection against lower respiratory infections in a high-risk infant cohort with a microbial-derived immunomodulator
-
Global impact of the COVID-19 on the environment
-
Proteomic and biological analysis of human in vitro vascular smooth muscle cell system in response to anaphylaxis
-
Personalized nutrition approach towards better QOL in Food Allergy
-
Alergia molecular na seleção de extratos para imunoterapia aos ácaros
-
MRGPRX2 and immediate drug hypersensitivity: Evidence from human mast cell silencing
-
Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab
-
Implementation of a novel DBS-based methodology to diagnose hereditary angioedema in subjects with recurrent abdominal pain of unclear etiology – the international EHA study
-
Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG
-
ÖGAI: Covid as best practice model to combine immunology and allergy
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Vaccines- Is this the tool to end the pandemic?
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy
-
New visions for managing anaphylaxis. Lesson from EAACI guidelines
-
Venom immunotherapy in predominant Api m 10 sensitization: Does it work?
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
The underlying immunology of pruritus
-
How does Type 2 mucosal inflammation influence susceptibility to SARS-CoV-2?
-
Innate trained immunity: An evolutionary perspective
-
BAT in clinical practice. Is it possible?
-
Potential usefulness of in-vitro tools for identifying aeroallergens sensitization in suspected local allergic rhinitis
-
T cell-based laboratory tests for diagnosis in clinical practice?
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
Influence of antigen density and TLR ligands on efficacy of a VLP-based vaccine against Peanut Allergy: mechanistic insights
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Contact urticaria and protein contact dermatitis connecting skin and airways
-
Good safety profile, efficacy and few withdrawals during oral immunotherapy with characterised GMP peanut protein in a real-world setting
-
Hand eczema during the COVID-19 pandemic
-
A controlled naturalistic approach to the study of allergic conjunctivitis (AC) in an environmental exposure chamber (EEC)
-
Practical Course on Big data analysis: transcriptomics, metabolomics, CyTOF and flow cytometryView Presentation
-
The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Epithelial cell barrier and allergic diseases
Show more Event Resources (351)Show Less-